Loading...
01/10 16:41
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance, with significant revenue and margin growth, and positive developments in acquisitions and injury prevention. The Q&A indicates solid demand and effective labor management strategies, with AI tools enhancing efficiency. The introduction of a buyback program and slight commercial rate increases further boost sentiment. While there are some uncertainties, such as Medicare rate changes and staffing challenges, the overall outlook is optimistic. Given the company's small-cap status, the positive factors are likely to result in a stock price increase of 2% to 8%.
Visits per clinic per day 32.7, up from last year's record of 30.6. The increase is attributed to happy patients who refer others and return for care.
Net Promoter Score 93.5, significantly higher than the healthcare industry average of 30-50. This reflects high patient satisfaction.
Injury Prevention Revenue Up 22.6% year-over-year. Gross profit increased by 25.8%. Growth driven by large contracts, including new ones in the auto industry.
Physical Therapy Revenue $168.3 million, a 17.3% increase year-over-year. Growth driven by acquisitions and exceeding 3 million visits year-to-date.
Medicare Cuts Impact $25 million impact this year, with $5-6 million year-over-year reduction. Despite this, revenue grew over 20%.
Salaries and Related Costs Increased slightly by 0.7% per visit, but overall cost per visit decreased slightly due to operational efficiencies.
Gross Profit Margin (Physical Therapy) 21.1%, up from 20.1% in the prior year quarter. Improvement attributed to revenue growth and cost management.
Adjusted EBITDA $26.9 million, up $4.7 million from the prior year quarter. Adjusted EBITDA margin expanded to 17.5% from 16.4%.
Workers' Compensation Revenue 10.4% of net patient revenues, with visits increasing 8.4% year-over-year. Focus on higher net rate business.
IIP Organic Revenue Growth 18.4% increase year-over-year. Gross profit up 21.8%. Margin improved to 22% from 21.4%.
Net Rate per Patient Visit $105.33, slightly up from $105.05 last year. Growth achieved despite Medicare rate reduction and policy changes in Michigan.
Operating Results $12.4 million, up from $11 million in the prior year quarter. Per share earnings increased to $0.81 from $0.73.
Net Promoter Score: Achieved a score of 93.5, significantly higher than the industry standard of 30-50, indicating high patient satisfaction.
Cash-based programs: Generated $900,000 in additional revenue, showing traction in new service offerings.
Industrial Injury Prevention (IIP) partnerships: Revenues increased by 22.6%, with gross profit up 25.8%. New large contracts in the auto industry are expected to drive further growth.
Physical therapy clinic expansion: Added over 50 net clinics compared to the prior year, exceeding 3 million visits year-to-date.
Operational cost management: Total operating costs per visit decreased year-over-year, and salaries increased by only 0.7%.
Adjusted EBITDA: Increased to $26.9 million, up $4.7 million from the prior year, with a margin expansion to 17.5%.
Acquisitions and home care business: Acquired Metro PT in New York, adding home care services and reporting 28,493 home care visits in Q2 2025.
Share repurchase program: Authorized a $25 million share repurchase program through December 31, 2026, while maintaining acquisitions as the primary capital allocation priority.
Medicare Cuts: Sequential Medicare rate cuts over the years have resulted in a cumulative impact of $25 million, with a $5-6 million year-over-year impact in 2025. This represents a significant headwind, reducing earnings by 8-8.5% compared to the prior year.
Staffing Challenges: Some markets are experiencing tight staffing conditions, which have constrained growth in mature facilities and impacted same-store growth, which was slightly over 1% but below normal expectations.
Regulatory and Payer Policy Changes: A 2.9% Medicare rate reduction at the beginning of the year and a policy change by the largest payer in Michigan negatively impacted net rates, creating additional financial headwinds.
Cost Management Pressures: While salaries and related costs increased slightly (0.7%), overall cost per visit decreased. However, managing costs effectively remains a challenge to sustain profitability.
Implementation Costs for New Systems: The company is incurring costs related to the implementation of a new enterprise-wide financial and human resources system, which will continue through 2026, adding to operational expenses.
Adjusted EBITDA Guidance: The company has increased its full-year 2025 adjusted EBITDA guidance to a range of $93 million to $97 million, up from the previous range of $88 million to $93 million.
Injury Prevention Business: The company plans to focus heavily on its injury prevention business due to its strong organic growth, high margins, and performance. It is expanding industry verticals and service offerings in this space and is competing for and winning large contracts.
Physical Therapy Business: The company expects continued growth in physical therapy revenues, driven by acquisitions and organic growth. It is also focusing on increasing reimbursement rates through targeted contract negotiations and growing its higher net rate workers' compensation business.
Cash-Based Programs: The company is rolling out cash-based programs, which have generated approximately $900,000 in additional revenue and are expected to continue ramping up.
Enterprise-Wide Financial and HR System: The company is in the early stages of implementing a new enterprise-wide financial and human resources system, with implementation costs expected to continue through 2026.
Share Repurchase Program: The Board of Directors authorized a share repurchase program, providing the flexibility to repurchase up to $25 million of shares through December 31, 2026, if market conditions are appropriate. However, acquisitions will continue to be the primary capital allocation priority, consistent with the company's strategic growth strategy.
The earnings call summary and Q&A indicate positive sentiment due to increased EBITDA guidance, strong growth in the injury prevention segment, and favorable financial metrics. The prioritization of acquisitions over buybacks, efficient recruitment strategies, and sustainable growth in key segments further bolster this outlook. While there are some uncertainties, such as the Medicare rate impact, the overall sentiment remains positive, suggesting a likely stock price increase of 2% to 8% over the next two weeks, considering the company's small market cap.
The earnings call highlights strong financial performance, with significant revenue and margin growth, and positive developments in acquisitions and injury prevention. The Q&A indicates solid demand and effective labor management strategies, with AI tools enhancing efficiency. The introduction of a buyback program and slight commercial rate increases further boost sentiment. While there are some uncertainties, such as Medicare rate changes and staffing challenges, the overall outlook is optimistic. Given the company's small-cap status, the positive factors are likely to result in a stock price increase of 2% to 8%.
The earnings call reveals a mixed outlook: strong revenue growth from acquisitions and IIP, but declining margins and economic concerns. Q&A insights highlight weather impacts, economic resilience, and lobbying efforts, but lack clarity on inflation adjustments. No share repurchase program or guidance changes were announced. The market cap suggests moderate volatility, but the absence of strong catalysts or negative surprises leads to a neutral prediction.
The earnings call presents mixed signals. Strong revenue growth and acquisitions are positive, but lower margins and increased operating costs raise concerns. The Q&A indicates economic uncertainties and challenges in rate negotiations. The share repurchase program is positive, but lack of detail tempers enthusiasm. The market cap suggests moderate volatility, aligning with a neutral sentiment.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
